FTC Sends Full Refunds to Consumers who Bought Deceptively Marketed Fish Oil Supplement
The Federal Trade Commission is sending refunds totaling $396,431 to more than 1,800 consumers nationwide who bought Hepaxa and Hepaxa PD, two fish oil supplements that were marketed as treatments for adults and children with non-alcoholic fatty liver disease (NAFLD).